SCHEMBL16180534

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL19608193	0.77	CCR1 (0.44)	NOS1NOS3NOS2KDM4EALDH1A1
	SCHEMBL684128	0.76	—	—
	SCHEMBL20373738	0.75	GBA1 (0.42)	GBA1GRM2MBOAT4KDM4EALDH1A1
	SCHEMBL507025	0.73	—	—
	SCHEMBL3231706	0.72	GBA1 (0.52)	GBA1GRM2MBOAT4KDM4EALDH1A1
	SCHEMBL31729646	0.72	GBA1 (0.52)	GBA1GRM2MBOAT4KDM4EALDH1A1
	SCHEMBL25921510	0.72	NOS3 (0.36)	NOS1NOS3NOS2MBOAT4
	SCHEMBL20376261	0.72	NOS3 (0.36)	NOS1NOS3NOS2
	SCHEMBL15334882	0.71	—	—
	SCHEMBL22703601	0.71	—	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.